These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1757 related articles for article (PubMed ID: 8226281)

  • 1. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits tumor cell-induced platelet aggregation.
    Sheu JR; Lin CH; Peng HC; Teng CM; Huang TF
    Jpn J Cancer Res; 1993 Oct; 84(10):1062-71. PubMed ID: 8226281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
    Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
    Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells.
    Chiang HS; Yang RS; Huang TF
    Br J Cancer; 1995 Feb; 71(2):265-70. PubMed ID: 7841039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of platelet aggregation induced by human breast carcinoma and its inhibition by snake venom peptides, trigramin and rhodostomin.
    Chiang HS; Swaim MW; Huang TF
    Breast Cancer Res Treat; 1995 Mar; 33(3):225-35. PubMed ID: 7749150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of platelet aggregation induced by human colon adenocarcinoma cells and its inhibition by snake venom peptides, trigramin and rhodostomin.
    Chiang HS; Swaim MW; Huang TF
    Br J Haematol; 1994 Jun; 87(2):325-31. PubMed ID: 7947275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of platelet aggregation induced by PC-3 human prostate adenocarcinoma cells and inhibited by venom peptides, trigramin and rhodostomin.
    Swaim MW; Chiang HS; Huang TF
    Eur J Cancer; 1996 Apr; 32A(4):715-21. PubMed ID: 8695278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triflavin, an Arg-Gly-Asp-containing antiplatelet peptide inhibits cell-substratum adhesion and melanoma cell-induced lung colonization.
    Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
    Jpn J Cancer Res; 1992 Aug; 83(8):885-93. PubMed ID: 1399825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
    Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
    J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits human cervical carcinoma (HeLa) cell-substratum adhesion through an RGD-dependent mechanism.
    Sheu JR; Lin CH; Peng HC; Huang TF
    Peptides; 1994; 15(8):1391-8. PubMed ID: 7700842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of thrombin-activated platelets with extracellular matrices (fibronectin and vitronectin): comparison of the activity of Arg-Gly-Asp-containing venom peptides and monoclonal antibodies against glycoprotein IIb/IIIa complex.
    Sheu JB; Ko WC; Hung WC; Peng HC; Huang TF
    J Pharm Pharmacol; 1997 Jan; 49(1):78-84. PubMed ID: 9120775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tumor cell-induced platelet aggregation and experimental tumor metastasis by the synthetic Gly-Arg-Gly-Asp-Ser peptide.
    Ugen KE; Mahalingam M; Klein PA; Kao KJ
    J Natl Cancer Inst; 1988 Nov; 80(18):1461-6. PubMed ID: 3184195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triflavin, an Arg-Gly-Asp-Containing Peptide, Inhibits B16-F10 Mouse Melanoma Cell Adhesion to Matrix Proteins via Direct Binding to Tumor Cells.
    Sheu JR; Huang TF
    J Biomed Sci; 1996; 3(5):359-364. PubMed ID: 11725118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triflavin inhibits platelet-induced vasoconstriction in de-endothelialized aorta.
    Sheu JR; Yen MH; Hung WC; Lee YM; Su CH; Huang TF
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3461-8. PubMed ID: 9437193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protracted treatment with phorbol ester modulates J-7 human hepatoma-cell-induced aggregation and coagulation of human platelet-rich plasma.
    Ko FN; Yu SM; Teng CM
    Int J Cancer; 1994 Dec; 59(5):706-11. PubMed ID: 7960244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
    Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
    Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.
    Huang TF; Sheu JR; Teng CM
    Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):351-7. PubMed ID: 1859363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells.
    Kitagawa H; Yamamoto N; Yamamoto K; Tanoue K; Kosaki G; Yamazaki H
    Cancer Res; 1989 Feb; 49(3):537-41. PubMed ID: 2910473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells.
    Sheu JR; Lin CH; Peng HC; Huang TF
    Proc Soc Exp Biol Med; 1996 Oct; 213(1):71-9. PubMed ID: 8820826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex-vivo and in-vivo antithrombotic effect of triflavin, an RGD-containing peptide.
    Sheu JR; Huang TF
    J Pharm Pharmacol; 1994 Jan; 46(1):58-62. PubMed ID: 8201528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triflavin, an Arg-Gly-Asp-containing peptide, prevents platelet plug formation in in vivo experiments.
    Sheu JR; Yen MH; Peng HC; Chang MC; Huang TF
    Eur J Pharmacol; 1995 Dec; 294(1):231-8. PubMed ID: 8788436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 88.